Ladasten in neurasthenia and somatogenic asthenia: safety and therapeutic efficacy
Randomized study in people · 2009
- What was studied
- 40 patients: 20 per diagnosis, randomized within diagnosis to active treatment or placebo (10 per cell)
- Main finding
- Single-blind, stratified randomized comparison reported symptom improvement over 28 days. Mild restlessness during treatment and transient dizziness after withdrawal were reported.
Reported findings and study design
40 patients: 20 with each of two diagnoses, randomized within diagnosis to active drug or placebo; four cells of ten. Single-blind, 28-day treatment and seven-day post-treatment observation.
Population or model 40 patients: 20 per diagnosis, randomized within diagnosis to active treatment or placebo (10 per cell)
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Symptom improvement | Reported over 28 days | Numerical table values were not transcribed in the prior review |
| Harms described | Mild restlessness during treatment; transient dizziness after withdrawal | Event denominators not supplied in the checked narrative |
Existing publisher methods and narrative review used. Table recovery is deferred; possible overlap with other 2009 reports remains unresolved.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Four small groups; multiple symptom outcomes.
- Seven-day post-treatment observation cannot establish long-term dependence or safety.
- Overlap with other 2009 Ladasten reports remains unresolved; do not sum cohorts.
Related publications may describe some of the same participants or experiments.
Source details
Publisher HTML article
Publisher methods, results and harms narrative checked; image tables not independently transcribed.
Methods, results and harms narrative
Sources checked
Citation
A. S. Avedisova, T. Yu. Kulikova, O. I. Mikhailova. Ladasten in neurasthenia and somatogenic asthenia: safety and therapeutic efficacy Mental Disorders in General Medicine. 2009(1):57–60